Evidence map›Paper›PMID 37245177›Full record

ReviewCellular oncology (Dordrecht, Netherlands)2023

Crosstalk between long noncoding RNA and microRNA in Cancer.

Rahul Bhattacharjee, Neeraj Prabhakar, Lamha Kumar, Arkadyuti Bhattacharjee, Sulagna Kar, Sumira Malik, Dhruv Kumar, Janne Ruokolainen, Arvind Negi, Niraj Kumar Jha and 1 more

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cellular oncology (Dordrecht, Netherlands), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Rahul BhattacharjeeKIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar, Odisha, India.
Neeraj PrabhakarCentre for Structural System Biology, Department of Physics, University of Hamburg, c/o DESY, Building 15, Notkestr. 852267, Hamburg, Germany.
Lamha KumarSchool of Biology, Indian Institute of Science Education and Research, Thiruvananthapuram, India.
Arkadyuti BhattacharjeeKIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar, Odisha, India.
Sulagna KarKIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar, Odisha, India.
Sumira MalikAmity Institute of Biotechnology, Amity University Jharkhand, Ranchi, Jharkhand, 834001, India.
Dhruv KumarSchool of Health Sciences and Technology (SoHST), UPES University, Dehradun, Uttarakhand, India.
Janne RuokolainenDepartment of Applied Physics, School of Science, Aalto University, Espoo, 00076, Finland.
Arvind NegiDepartment of Bioproducts and Biosystems, School of Chemical Engineering, Aalto University, Espoo, 00076, Finland. arvindnegi2301@gmail.com.
Niraj Kumar JhaDepartment of Biotechnology, School of Engineering and Technology (SET), Sharda University, Greater Noida, 201310, UP, India. nirajkumarjha2011@gmail.com.
Kavindra Kumar KesariDepartment of Applied Physics, School of Science, Aalto University, Espoo, 00076, Finland. kavindra.kesari@helsinki.fi.ORCID http://orcid.org/0000-0003-3622-9555
KIIT University · INAalto University · FIÅbo Akademi University · FIIndian Institute of Science Education and Research Thiruvananthapuram · INLovely Professional University · INUniversity of Helsinki · FIUniversity of Petroleum and Energy Studies · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

miRNAs and lncRNAs play a central role in cancer-associated gene regulations. The dysregulated expression of lncRNAs has been reported as a hallmark of cancer progression, acting as an independent prediction marker for an individual cancer patient. The interplay of miRNA and lncRNA decides the variation of tumorigenesis that could be mediated by acting as sponges for endogenous RNAs, regulating miRNA decay, mediating intra-chromosomal interactions, and modulating epigenetic components. This paper focuses on the influence of crosstalk between lncRNA and miRNA on cancer hallmarks such as epithelial-mesenchymal transition, hijacking cell death, metastasis, and invasion. Other cellular roles of crosstalks, such as neovascularization, vascular mimicry, and angiogenesis were also discussed. Additionally, we reviewed crosstalk mechanism with specific host immune responses and targeting interplay (between lncRNA and miRNA) in cancer diagnosis and management.

Indexed as

MicroRNAsNeoplasmsRNA, Long NoncodingEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticHumansNeovascularization, PathologicMicroRNAsRNA, Long NoncodingAngiogenesisCancerEpithelial-mesenchymal transitionLong-noncoding RNAMetastasisMicroRNANeovascularizationVascular mimicry

Identifiers

PMID37245177
PMCPMC10356678
OpenAlexW4378597171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.